There have been news stories recently about ‘shortages’ in prescription drugs, including some cancer medications. Makes me wonder how long can daily medication be interrupted without serious effects?
I am presently on Nubeqa and it has been quite effective, but I wonder how many days could be missed with little to no effect on my treatment.
Written by
Pinkyboy
To view profiles and participate in discussions please or .
You have enough to worry about! You don’t need to worry about hypothetical scenarios that most likely won’t happen. Jeez we have enough to worry about.
I read your bio and you should try exercising with bands. That’s what most of us use as free weights can be a little dangerous for our weakened bones, tendons and muscles.
I use cable, bands and light free weights.
Your knee injury is perfect for bands! Watch some youtube on band exercises for injured knee.
If nubeqa was running low I believe priority would be to trials then existing patients. I would also imagine the doctors could prescribe other AR inhibitors like enzalutamide or appalutamide.
The biggest issue is the Bayer would lose millions of dollars per day so some heads would roll. It won’t happen as long as big money could be lost.
How long a medication can be interrupted is variable, based upon each drug’s pharmacokinetics. There is no blanket answer. Also, many meds have similar drugs within the same class, so I wouldn’t worry too much.
Darolutamide is primarily metabolized by CYP3A4, as well as by UGT1A9 and UGT1A1. Ketodarolutamide total exposure in plasma is 1.7‑fold higher compared to darolutamide.
Excretion
After a single radiolabeled dose as an oral solution, a total of 63.4% of darolutamide‑related material is excreted in the urine (approximately 7% unchanged) and 32.4% (approximately 30% unchanged) in the feces. More than 95% of the dose was recovered within 7 days after administration
Darolutamide Cmax is reached approximately 4 hours after administration of a single 600 mg oral dose.
The absolute bioavailability is approximately 30% following oral administration of a NUBEQA tablet containing 300 mg darolutamide under fasted conditions.
Food Effect
Bioavailability of darolutamide increased by 2.0- to 2.5‑fold when administered with food. A similar increase of exposure was observed for the active metabolite ketodarolutamide.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.